As Benzinga Cannabis Capital Conference returns (September 13-14) to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the space.
PharmaCielo Announces New Appointments
PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts PharmaCielo Colombia Holdings S.A.S., announced that its CFO Ian D. Atacan was appointed to the company's board of directors.
"I am pleased to welcome Ian to the board of directors," said Bill Petron, CEO of PharmaCielo. "With more than 30 years of experience in strategy, M&A, and financial management, he is well positioned to help shape the design and implementation of the Company's strategic initiatives."
In addition, Dr. Decio Rabelo de Castro Filho was tapped to serve as chief medical officer to advance the company's visibility within physician communities and pharmaceutical organizations in Latin America, Europe and other key global markets.
Castro Filho is a medical doctor with over 20 years of experience in occupational medicine and marketing.